Mostrando 4 resultados de: 4
Filtros aplicados
Subtipo de publicación
Article(4)
Publisher
European Journal of Cancer and Clinical Oncology(1)
European Journal of Clinical Pharmacology(1)
Journal of Neurology Neurosurgery and Psychiatry(1)
Oncology(1)
Área de conocimiento
Genética(2)
Origen
scopus(4)
Acetylator polymorphism in Parkinson's disease
ArticleAbstract: Acetylator phenotype has been determined using sulphamethazine in 100 patients with Parkinson's disePalabras claves:acetylator phenotype, debrisoquine oxidation, drug polymorphism, Parkinsonism, sulphamethazineAutores:Adrián LLerena, Benitez Rodriguez J., Cobaleda J., Fernandez-Gundin M.J., Jimenez F.J., Ladero J.M., Martinez C., Muñoz J.J.Fuentes:scopusOxidative polymorphism of debrisoquine in Parkinson's disease
ArticleAbstract: Oxidative phenotype and metabolic ratio (MR) of debrisoquine (DBQ) have been determined in 87 patienPalabras claves:Autores:Adrián LLerena, Benitez Rodriguez J., Cobaleda J., Jimenez-Jimenez F.J., Ladero J.M., Martínez C., Muñoz J.J., Puerto A.M., Valdivielso M.J.Fuentes:scopusPolymorphic oxidation of debrisoquine in lung cancer patients
ArticleAbstract: Oxidative polymorphism of debrisoquine (DBQ) was assessed in 84 patients (81 male) with histologicalPalabras claves:Autores:Adrián LLerena, Benitez Rodriguez J., Carrillo J.A., Cobaleda J., Jara C., Ladero J.M., Muñoz J.J., Vargas E.Fuentes:scopusPolymorphic oxidation of debrisoquine in women with breast cancer
ArticleAbstract: Oxidative polymorphism of debrisoquine (DBQ) was determined in 98 women with breast cancer (mean agePalabras claves:Breast Cancer, debrisoquine, OXIDATION, Oxidative polymorphismAutores:Adrián LLerena, Benitez Rodriguez J., Jara C., Ladero J.M., Muñoz J.J., Valdivielso M.J., Vargas E.Fuentes:scopus